Shalini Sharp, CFO & Senior Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 4,000 shares at $95.95 ($384K) on 2015-06-18, disclosed to the SEC on 2015-06-19.
Scheduled sale ($384k) by CFO & Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.95 | 2,651 | $254K | 66.2% |
| 2 | $96.35 | 1,349 | $130K | 33.8% |
| Total | $96.08 avg | 4,000 | $384K | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |